Study protocol for the Multimodal Approach to Preventing Suicide in Schools (MAPSS) project: a regionally based randomised trial of an integrated response to suicide risk among secondary school students.
Psychoeducation
Schools
Screening
Suicide prevention
iCBT
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
02 Mar 2022
02 Mar 2022
Historique:
received:
05
04
2021
accepted:
31
01
2022
entrez:
3
3
2022
pubmed:
4
3
2022
medline:
5
3
2022
Statut:
epublish
Résumé
Suicide is the leading cause of death among young Australians, accounting for one-third of all deaths in those under 25. Schools are a logical setting for youth suicide prevention activities, with universal, selective and indicated approaches all demonstrating efficacy. Given that international best practice recommends suicide prevention programmes combine these approaches, and that to date this has not been done in school settings, this study aims to evaluate a suicide prevention programme incorporating universal, selective and indicated components in schools. This study is a trial of a multimodal suicide prevention programme for young people. The programme involves delivering universal psychoeducation (safeTALK) to all students, screening them for suicide risk, and delivering internet-based Cognitive Behavioural Therapy (Reframe IT) to those students identified as being at high risk for suicide. The programme will be trialled in secondary schools in Melbourne, Australia, and target year 10 students (15 and 16 year-olds). safeTALK and screening will be evaluated using a single group pre-test/post-test case series, and Reframe IT will be evaluated in a Randomised Controlled Trial. The primary outcome is change in suicidal ideation; other outcomes include help-seeking behaviour and intentions, and suicide knowledge and stigma. The programme's cost-effectiveness will also be evaluated. This study is the first to evaluate a suicide prevention programme comprising universal, selective and indicated components in Australian schools. If the programme is found to be efficacious and cost-effective, it could be more widely disseminated in schools and may ultimately lead to reduced rates of suicide and suicidal behaviour in school students across the region.
Sections du résumé
BACKGROUND
BACKGROUND
Suicide is the leading cause of death among young Australians, accounting for one-third of all deaths in those under 25. Schools are a logical setting for youth suicide prevention activities, with universal, selective and indicated approaches all demonstrating efficacy. Given that international best practice recommends suicide prevention programmes combine these approaches, and that to date this has not been done in school settings, this study aims to evaluate a suicide prevention programme incorporating universal, selective and indicated components in schools.
METHODS
METHODS
This study is a trial of a multimodal suicide prevention programme for young people. The programme involves delivering universal psychoeducation (safeTALK) to all students, screening them for suicide risk, and delivering internet-based Cognitive Behavioural Therapy (Reframe IT) to those students identified as being at high risk for suicide. The programme will be trialled in secondary schools in Melbourne, Australia, and target year 10 students (15 and 16 year-olds). safeTALK and screening will be evaluated using a single group pre-test/post-test case series, and Reframe IT will be evaluated in a Randomised Controlled Trial. The primary outcome is change in suicidal ideation; other outcomes include help-seeking behaviour and intentions, and suicide knowledge and stigma. The programme's cost-effectiveness will also be evaluated.
DISCUSSION
CONCLUSIONS
This study is the first to evaluate a suicide prevention programme comprising universal, selective and indicated components in Australian schools. If the programme is found to be efficacious and cost-effective, it could be more widely disseminated in schools and may ultimately lead to reduced rates of suicide and suicidal behaviour in school students across the region.
Identifiants
pubmed: 35236397
doi: 10.1186/s13063-022-06072-8
pii: 10.1186/s13063-022-06072-8
pmc: PMC8889397
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
186Subventions
Organisme : National Health and Medical Research Council (AUS)
ID : GNT1153051
Informations de copyright
© 2022. The Author(s).
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
JAMA. 2005 Apr 6;293(13):1635-43
pubmed: 15811983
Psychol Med. 2014 Dec;44(16):3361-3
pubmed: 24998511
Behav Res Ther. 2005 Mar;43(3):391-401
pubmed: 15680933
Early Interv Psychiatry. 2015 Dec;9(6):498-506
pubmed: 24684927
J Med Internet Res. 2014 Jan 28;16(1):e30
pubmed: 24472876
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Crisis. 2013 Jan 1;34(1):13-21
pubmed: 22846447
J Consult Clin Psychol. 1986 Apr;54(2):241-5
pubmed: 3700812
J Clin Epidemiol. 2016 Mar;71:35-42
pubmed: 26464194
Evid Based Ment Health. 2017 Aug;20(3):76-82
pubmed: 28701336
Suicide Life Threat Behav. 2014 Aug;44(4):408-19
pubmed: 24612048
J Sch Health. 2011 Sep;81(9):581-90
pubmed: 21831072
EClinicalMedicine. 2018 Oct 28;4-5:52-91
pubmed: 31193651
Am J Public Health. 2010 Sep;100(9):1653-61
pubmed: 20634440
Br J Psychiatry. 2003 Jun;182:537-42
pubmed: 12777346
Vet Rec. 2010 Nov 6;167(19):730-4
pubmed: 21257507
Arch Suicide Res. 2020 Jul 25;:1-23
pubmed: 32715986
Lancet Digit Health. 2020 Jan;2(1):e25-e36
pubmed: 33328037
Suicide Life Threat Behav. 2013 Aug;43(4):406-17
pubmed: 23556504
Aust N Z J Psychiatry. 2016 Sep;50(9):887-98
pubmed: 26769979
J Affect Disord. 2018 May;232:34-40
pubmed: 29477096
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
BMC Public Health. 2007 Jul 18;7:161
pubmed: 17640366
Value Health. 2012 Dec;15(8):1092-9
pubmed: 23244812
BMC Psychiatry. 2016 Nov 22;16(1):417
pubmed: 27876026
Clin Psychol Rev. 2018 Aug;64:1-12
pubmed: 30014862
Trials. 2010 Mar 24;11:32
pubmed: 20334632
Trials. 2016 Jul 26;17(1):349
pubmed: 27456094
Lancet. 2015 Apr 18;385(9977):1536-44
pubmed: 25579833
Early Interv Psychiatry. 2016 Feb;10(1):28-35
pubmed: 24684946
Suicide Life Threat Behav. 2006 Dec;36(6):614-37
pubmed: 17250467
Psychol Sci. 2012 Jul 1;23(7):780-7
pubmed: 22623507
Am J Public Health. 2009 Feb;99(2):334-9
pubmed: 19059865
Crisis. 2017 Sep;38(5):300-308
pubmed: 29098895
Psychother Psychosom. 2009;78(5):275-84
pubmed: 19602916
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Death Stud. 2014 Jan-Jun;38(1-5):100-8
pubmed: 24517708
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Inj Prev. 2011 Feb;17(1):43-9
pubmed: 21059602
Med J Aust. 2007 Oct 1;187(S7):S35-9
pubmed: 17908023
J Affect Disord. 2017 Jun;215:37-48
pubmed: 28315579
Suicide Life Threat Behav. 1999 Spring;29(1):72-85
pubmed: 10322622